Background: Human immunodeficiency virus (HIV) requires several host factors to complete viral replication cycle. Genome editing using zinc-finger nucleases (ZFN) has been successfully applied to disrupt CCR5 or CXCR4 host factors, inhibiting viral entry and infection. Lens epithelium-derived growth factor (LEDGF/p75) is a lentivirus-specific cellular cofactor which directly interacts with viral integrase, tethering viral preintegration complex into active transcription units of the cellular chromatin. Gene therapy using ZFN to modify LEDGF gene might restrain a late step of viral replication cycle at the integration level. Methodology: Knockout ZFNs targeting the LEDGF gene (ZFN-LEDGF) were designed to specifically target the sequence nearby the integration binding domain (IDB) of LEDGF/p75 protein. TZM-bl cells were transfected with ZFN-LEDGF expressing plasmids carrying a ZsGreen reporter gene. Moreover, LEDGF/p75 knock-out cells were infected with HIV-1 R5 tropic BaL and the X4 tropic NL4-3 strains and infection was monitored by proviral and integrated viral DNA at 24h post infection and β-galactosidase assay 3 days after infection. AZT, AMD3100 and raltegravir were used as controls. Results: A total of 15% of TZM-bl ZFN-LEDGF positive cells were obtained after transfection and cell sorting of GFP expressing cells. Assessment of ZFNLEDGF efficiency in the deletion of the gene by heteroduplex formation and DNA sequence analysis, revealed two homozygotic cell clones with deletions ranging from 17 to 41 bp surrounding the target sequence of ZFN-LEDGF. We confirmed that ZFN-LEDGF successfully recognized the target region of the LEDGF gene, induced a frame shift of the coding region and resulted in the abolishment of LEDGF expression at mRNA and protein level. Functional assays revealed that infection with R5 BaL or X4 NL43 viral strains was impaired in LEDGF knock-out cells regardless of entry tropism (up to 85% inhibition, p<0.05). Disruption of LEDGF gene restricted HIV-1 provirus integration into host genome. However, residual infection was detected in LEDGF knockout cells. Indeed, LEDGF knock-out restriction was overcome at high virus multiplicity of infection, suggesting alternative mechanisms for HIV-1 genome integration rather than LEDGF/p75. Observed residual integration was, however, sensitive to the integrase inhibitor raltegravir. Conclusions: Genome editing is an incoming issue for HIV-1 research and treatment. Here, we describe a novel ZFN that effectively targets LEDGF gene which is involved at late steps of viral replication cycle. LEDGF knock-out cells represent potent tools to elucidate the role of HIV integration cofactors in virus replication. The ZFN-LEDGF becomes a potential antiviral agent to restrict HIV-1 integration.